Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Chemotherapy for Adjuvant Esophageal Cancer
NCT03649945Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of endostar in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by The First Affiliated Hospital of Guangxi Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03649945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649945.